Dimenoxadol

Dimenoxadol

SCHEMBL2886211

CCOC(C(=O)OCCN(C)C)(c1ccccc1)c1ccccc1.Cl.Cl

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Dimenoxadol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 5/20 0.52
CHRM1 known ✓ P11229 5/20 0.52
CHRM3 known ✓ P20309 5/20 0.52
GAA known ✓ P10253 1/20 0.51
CHRM4 known ✓ P08173 3/20 0.50
CHRM5 known ✓ P08912 1/20 0.50
SCN1A known ✓ P35498 1/20 0.47
SCN2A known ✓ Q99250 1/20 0.47
SIGMAR1 known ✓ Q99720 1/20 0.47
SCN3A known ✓ Q9NY46 1/20 0.47
DRD2 known ✓ P14416 1/20 0.44
OPRM1 known ✓ P35372 1/20 0.44
DRD3 known ✓ P35462 1/20 0.44
CYP3A4 P08684 3/20 0.70
CYP2D6 P10635 3/20 0.70
LMNA P02545 3/20 0.57
POLB P06746 3/20 0.54
ALDH1A1 P00352 1/20 0.53
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimenoxadol SCHEMBL79044 1.00 CYP3A4 (0.70) CYP3A4CYP2D6LMNAPOLBALDH1A1
Dimenoxadol SCHEMBL5854258 0.99 CYP3A4 (0.69) CYP3A4CYP2D6LMNAPOLBALDH1A1
Dimenoxadol SCHEMBL25993 0.99 CYP3A4 (0.68) CYP3A4CYP2D6LMNAPOLBALDH1A1
Dimenoxadol SCHEMBL2204879 0.97 CYP3A4 (0.67) CYP3A4CYP2D6LMNAPOLBALDH1A1
Dimenoxadol SCHEMBL4580231 0.87 CYP3A4 (0.55) CYP3A4CYP2D6LMNAPOLBALDH1A1
Denaverine SCHEMBL9569397 0.86 CYP3A4 (0.54) CYP3A4CYP2D6LMNAPOLBALDH1A1
Pargeverine SCHEMBL30728632 0.85 CYP3A4 (0.53) CYP3A4CYP2D6LMNAPOLBALDH1A1
Denaverine SCHEMBL147346 0.84 CYP3A4 (0.52) CYP3A4CYP2D6LMNAPOLBALDH1A1
Pargeverine SCHEMBL2111437 0.84 CYP3A4 (0.51) CYP3A4CYP2D6LMNAPOLBALDH1A1
SCHEMBL27585378 0.82 CYP3A4 (0.63) CYP3A4CYP2D6LMNAPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812149-B1 SEMIPERMEABLE COMPOSITE MEMBRANE, PRODUCTION PROCESS THEREOF AND TREATMENT METHOD FOR BORON-CONTAINING WATER TORAY INDUSTRIES (JP) 2013-06-12 EP disclosed
US-7641054-B2 Composite semipermeable membrane, production process thereof, and element, fluid separation equipment and treatment method for boron-containing water using the same TORAY INDUSTRIES, INC. (JP) 2010-01-05 US disclosed
US-20080000843-A1 Composite Semipermeable Membrane, Production Process Thereof, and Element, Fluid Separation Equipment and Treatment Method for Boron-Containing Water Using the Same TORAY INDUSTRIES, INC. (JP) 2008-01-03 US disclosed
EP-1812149-A1 COMPOSITE SEMIPERMEABLE MEMBRANE, PRODUCTION PROCESS THEREOF, AND ELEMENT, FLUID SEPARATION EQUIPMENT AND TREATMENT METHOD FOR BORON-CONTAINING WATER USING THE SAME TORAY INDUSTRIES, INC. (JP) 2007-08-01 EP disclosed
WO-2006051888-A1 COMPOSITE SEMIPERMEABLE MEMBRANE, PRODUCTION PROCESS THEREOF, AND ELEMENT, FLUID SEPARATION EQUIPMENT AND TREATMENT METHOD FOR BORON-CONTAINING WATER USING THE SAME TORAY INDUSTRIES, INC. (JP) 2006-05-18 WO disclosed
EP-1266903-B1 Method of preparing an organosilicon compound DOW CORNING ASIA LTD (JP) 2004-09-29 EP disclosed
EP-1266903-A1 Method of preparing an organosilicon compound DOW CORNING ASIA, Ltd. (JP) 2002-12-18 EP disclosed
US-6326506-B1 HYDROSILATION DOW CORNING ASIA, LTD. (JP) 2001-12-04 US disclosed
US-5196583-A Polymerizable coating, reaction injection molding material NIPPON PAINT CO., LTD. (JP) 1993-03-23 US disclosed
EP-0431700-A2 Propargyl compounds, and preparation thereof NIPPON PAINT CO., LTD. (JP) 1991-06-12 EP disclosed